Influence of polymer blends on the characterization of gliclazide – encapsulated into poly (Æ-caprolactone) microparticles

References

• Thombre AG, Cardinal JR. (1990). Biopolymers for controlled drug delivery. In: Swarbick J, Boylan JC, eds. Encyclopedia of Pharmaceutical Technology. Volume 2. New York: Marcel Dekker, 61–88.
   Google Scholar
• Pitt CG. (1990). Poly-ϵ-caprolactone and its copolymers. In: Chasin M, Langer R, eds. Biodegradable polymers as drug delivery systems. New York: Marcell Dekker Inc., 71–120.
   Google Scholar
• Pitt CG, Shindler A. (1984). Capronor: a biodegradable delivery system for levonorgestrel. In: Zatuchni GI, Goldsmith A, Shelton JD, Sciarra JJ, eds. Long-acting contraceptive delivery systems. Philadelphia: Harper and Row, 48–63.
   Google Scholar
• Baras B, Benoit MA, Gillard J. (2000). Influence of various technological parameters on the preparation of spray-dried poly(epsilon-caprolactone) microparticles containing a model antigen. J Microencapsul, 17:485–498.
   PubMed Web of Science ®Google Scholar
• Benoit MA, Baras B, Gillard J. (1999). Preparation and characterization of protein-loaded poly(epsilon-caprolactone) microparticles for oral vaccine delivery. Int J Pharm, 184:73–84.
   PubMed Web of Science ®Google Scholar
• Giunchedi P, Conti B, Maggi L, Conte U. (1994). Cellulose acetate butyrate and polycaprolactone for ketoprofen spray-dried microsphere preparation. J Microencapsul, 11:381–393.
   PubMed Web of Science ®Google Scholar
• Buntner B, Nowak M, Kasperczyk J, Ryba M, Grieb P, Walski M et al. (1998). The application of microspheres from the copolymers of lactide and epsilon-caprolactone to the controlled release of steroids. J Control Release, 56:159–167.
   PubMed Web of Science ®Google Scholar
• Das GS, Rao GH, Wilson RF, Chandy T. (2000). Colchicine encapsulation within poly(ethylene glycol)-coated poly(lactic acid)/poly(epsilon-caprolactone) microspheres-controlled release studies. Drug Deliv, 7:129–138.
   PubMed Web of Science ®Google Scholar
• Shen Y, Sun W, Zhu KJ, Shen Z. (2000). Regulation of biodegradability and drug release behavior of aliphatic polyesters by blending. J Biomed Mater Res, 50:528–535.
   PubMed Web of Science ®Google Scholar
• Koleske JV. (1978). Blends containing poly(ϵ-caprolactone) and related polymers. In: Paul DR, Newman S. Polymer Blends. Volume 2. New York: Academic Press, 369–389.
   Google Scholar
• Hoffart V, Ubrich N, Lamprecht A, Bachelier K, Vigneron C, Lecompte T et al. (2003). Microencapsulation of low molecular weight heparin into polymeric particles designed with biodegradable and nonbiodegradable polycationic polymers. Drug Deliv, 10:1–7.
   PubMed Web of Science ®Google Scholar
• Hoffart V, Lamprecht A, Maincent P, Lecompte T, Vigneron C, Ubrich N. (2006). Oral bioavailability of a low molecular weight heparin using a polymeric delivery system. J Control Release, 113:38–42.
   PubMed Web of Science ®Google Scholar
• Lin WJ, Flanagan DR, Linchardt RJ. (1998). A novel fabrication of poly (ϵ-caprolactone) microparticles from blends of poly (ϵ-caprolactone) and poly(ethylene glycol). Polymer, 40:1731–1735.
   Web of Science ®Google Scholar
• Nihant N, Schugens Ch, Grandfils C, Je´ro^me R, Bodmeier R, McGinity JW. (1994). Polylactic acid microparticles Teyssie´, Polylactide microparticles prepared by double emulsion-containing quinidine base and quinidine sulphate prepared by solvent/ evaporation technique. I. Effect of primary emulsion the solvent evaporation technique. I. Methods and morpholostability. Pharm Res, 11:1479–1484.
   PubMed Web of Science ®Google Scholar
• Schernthaner G. (2003). Gliclazide modified release: a critical review of pharmacodynamic, metabolic, and vasoprotective effects. Metab Clin Exp, 52:29–34.
   PubMed Web of Science ®Google Scholar
• Campbell DB, Lavielle R, Nathan C. (1991). The mode of action and clinical pharmacology of gliclazide: a review. Diabetes Res Clin Pract, 14 Suppl 2:S21–S36.
   PubMed Web of Science ®Google Scholar
• Barakat NS, Almurshedi AS. (2010). Preparation and characterization of chitosan microparticles for oral sustained delivery of gliclazide: pharmacokinetics evaluation. Drug Development Research, 72:235–246.
   Web of Science ®Google Scholar
• Liggins RT, D’Amours S, Demetrick JS, Machan LS, Burt HM. (2000). Paclitaxel loaded poly(L-lactic acid) microspheres for the prevention of intraperitoneal carcinomatosis after a surgical repair and tumor cell spill. Biomaterials, 21:1959–1969.
   PubMed Web of Science ®Google Scholar
• Hombreiro Pérez M, Zinutti C, Lamprecht A, Ubrich N, Astier A, Hoffman M et al. (2000). The preparation and evaluation of poly(epsilon-caprolactone) microparticles containing both a lipophilic and a hydrophilic drug. J Control Release, 65:429–438.
   PubMed Web of Science ®Google Scholar
• Dubey RR, Parikh RH. (2004). Studies of PLGA microspheres. Pharm Tech Eur, 16:23–34.
   Google Scholar
• Junyaprasert VB, Pornsuwannapha S. (2008). Floating properties and release characteristics of hollow microspheres of acyclovir. Drug Deliv, 15:331–341.
   PubMed Web of Science ®Google Scholar
• Ahuja N, Katare OP, Singh B. (2007). Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers. Eur J Pharm Biopharm, 65:26–38.
   PubMed Web of Science ®Google Scholar
• Kumar KE, Ramesh A, Yadav RS, Satyanarayana S. (2007). Determination of gliclazide in rabbit serum by RP-HPLC. Acta Ciencia Indica Chem, 33:273–278.
   Google Scholar
• Guidance for Industry-Q2B Validation of Analytical Procedures. (1996). Methodology. Londres: European Agency for the Evaluation of medicinal Products (ICH).
   Google Scholar
• Raffin RP, Colomé LM, Guterres SS, Pohlmann AR. (2007). Enteric controlled-release pantoprazole-loaded microparticles prepared by using Eudragit S100 and poly(epsilon-caprolactone) blend. Pharm Dev Technol, 12:463–471.
   PubMed Web of Science ®Google Scholar
• Comoglu T, Gonul N, Dogan A, Basci N. (2008). Development and in vitro evaluation of pantoprazole-loaded microspheres. Drug Deliv, 15:295–302.
   PubMed Web of Science ®Google Scholar
• Sengel CT, Hasçiçek C, Gönül N. (2006). Development and in-vitro evaluation of modified release tablets including ethylcellulose microspheres loaded with diltiazem hydrochloride. J Microencapsul, 23:135–152.
   PubMed Web of Science ®Google Scholar
• Tewa-Tagne P, Briançon S, Fessi H. (2007). Preparation of redispersible dry nanocapsules by means of spray-drying: development and characterisation. Eur J Pharm Sci, 30:124–135.
   PubMed Web of Science ®Google Scholar
• Kim CK, Kim MJ, Oh KH. (1994). Preparation and evaluation of sustained release micropspheres of terbutaline sulfate. Int J Pharmaceut, 106:213–219.
   Web of Science ®Google Scholar
• Craig DQ. (2002). The mechanisms of drug release from solid dispersions in water-soluble polymers. Int J Pharm, 231:131–144.
   PubMed Web of Science ®Google Scholar
• Nalva HS. (1997). Spectroscopy and physical properties. New York: John Wiley & Sons Ltd.
   Google Scholar
• Rosca ID, Watari F, Uo M. (2004). Microparticle formation and its mechanism in single and double emulsion solvent evaporation. J Control Release, 99:271–280.
   PubMed Web of Science ®Google Scholar
• Gibaud S, Jabir Al Awwadi N, Ducki C, Astier A. (2004). Poly(epsilon-caprolactone) and Eudragit microparticles containing fludrocortisone acetate. Int J Pharm, 269:491–508.
   PubMed Web of Science ®Google Scholar
• Yuksel N, Kanik AE, Baykara T. (2000). Comparison of in vitro dissolution profiles by ANOVA-based, model-dependent and -independent methods. Int J Pharm, 209:57–67.
   PubMed Web of Science ®Google Scholar
• Costa P, Sousa Lobo JM. (2001). Modeling and comparison of dissolution profiles. Eur J Pharm Sci, 13:123–133.
   PubMed Web of Science ®Google Scholar
• Ritger P, Peppas NA. (1987). A simple equation for description of solute release II: Fickian and anomalous release from swellable devices. J Control Release, 5:37–42.
   Google Scholar
• Ha J. -H, Kim S.-H, Han S.-Y. (1997). Albumin release from bioerodible hydrogels based on semi-interpenetrating polymer networks composed of poly(e-caprolactone) and poly- (ethylene glycol) macromer. J Control Release, 49:253–262.
   Web of Science ®Google Scholar
• Hoffart V, Ubrich N, Simonin C, Babak V, Vigneron C, Hoffman M et al. (2002). Low molecular weight heparin-loaded polymeric nanoparticles: formulation, characterization, and release characteristics. Drug Dev Ind Pharm, 28:1091–1099.
   PubMed Web of Science ®Google Scholar
• Jiao YY, Ubrich N, Hoffart V, Marchand-Arvier M, Vigneron C, Hoffman M et al. (2002). Preparation and characterization of heparin-loaded polymeric microparticles. Drug Dev Ind Pharm, 28:1033–1041.
   PubMed Web of Science ®Google Scholar